As of 2024-12-15, the EV/EBITDA ratio of Arena Pharmaceuticals Inc (ARNA) is -10.98. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ARNA's latest enterprise value is 5,982.02 mil USD. ARNA's TTM EBITDA according to its financial statements is -545.06 mil USD. Dividing these 2 quantities gives us the above ARNA EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 13.4x - 16.2x | 14.8x |
| Forward P/E multiples | 15.4x - 18.6x | 16.2x |
| Fair Price | (133.16) - (140.23) | (134.48) |
| Upside | -233.2% - -240.2% | -234.5% |
| Date | EV/EBITDA |